Brief: Cullinan And Taiho To Jointly Develop And Commercialize Cln-081/Tas6417 And Taiho's Acquisition Of Cullinan Pearl

Cullinan Therapeutics

12/05/2022 07:06

May 12 (Reuters) - Cullinan Oncology Inc  CGEM.O :
    * CULLINAN ONCOLOGY AND TAIHO PHARMACEUTICAL ANNOUNCE
STRATEGIC
COLLABORATION TO JOINTLY DEVELOP AND COMMERCIALIZE
CLN-081/TAS6417 AND TAIHO'S ACQUISITION OF CULLINAN PEARL

Source text for Eikon:  ID:nGNX13whzh 
Further company coverage:  CGEM.O 

 ((Reuters.Briefs@thomsonreuters.com;))